Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry

Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry

Saved in:

Bibliographic Details
Main Authors:	Barbara Kind, Luise Heinrich, Thomas Werfel, Jochen Schmitt, Stephan Weidinger
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-05-01
Series:	Acta Dermato-Venereologica
Subjects:	atopic dermatitis upadacitinib JAK inhibitor
Online Access:	https://medicaljournalssweden.se/actadv/article/view/42206
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
by: Edoardo Mortato, et al.
Published: (2025-12-01)

Vitiligo exacerbation during upadacitinib treatment for atopic dermatitis and improvement following a switch to abrocitinib: a case report
by: Zhaoyang Wang, et al.
Published: (2025-12-01)

Experience of using the drug upadacitinib in a child with severe atopic dermatitis
by: G. D. Alemanova, et al.
Published: (2025-06-01)

Upadacitinib in daily practice for refractory atopic dermatitis in adolescents: a case series of the BioDay registry
by: Florence Vroman, et al.
Published: (2025-12-01)

Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies
by: Claudia Paganini, et al.
Published: (2025-03-01)

A Case of Upadacitinib-Associated Ileus Secondary to Psoriasis Induced by Treatment of Atopic Dermatitis with Dupilumab
by: Liu X, et al.
Published: (2024-12-01)

Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis
by: Akihiro Horie, et al.
Published: (2025-05-01)

Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study
by: Stephan Weidinger, et al.
Published: (2025-03-01)

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
by: Teppei Hagino, et al.
Published: (2024-12-01)

Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study
by: Tiago Torres, et al.
Published: (2025-06-01)

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
by: Teppei Hagino, et al.
Published: (2024-12-01)

Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis
by: Eric L. Simpson, et al.
Published: (2025-06-01)

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study
by: Nina Magnolo, et al.
Published: (2024-12-01)

Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)
by: Jonathan I. Silverberg, et al.
Published: (2025-07-01)

Upadacitinib Monotherapy for Treatment of Pyoderma Gangrenosum
by: Mohamad R. Taha, et al.
Published: (2025-12-01)

New-onset psoriasis with abrocitinib therapy for atopic dermatitis
by: Sarah L. Becker, BA, et al.
Published: (2025-07-01)

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
by: Jonathan I. Silverberg, et al.
Published: (2025-02-01)

Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
by: Daciana Elena Brănișteanu, et al.
Published: (2025-02-01)

Treatment of eosinophilic annular erythema with upadacitinib
by: Wanyan Xiang, et al.
Published: (2025-12-01)

Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
by: Sihan Wang, et al.
Published: (2025-01-01)

Pathogenetic role of IL-4 and IL-13 in atopic dermatitis: The inhibitory pathways
by: D. Sh. Macharadze
Published: (2025-03-01)

The progress of rheumatology in the 21st century potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases
by: E. L. Nasonov, et al.
Published: (2020-11-01)

Potential role of upadacitinib in cytomegalovirus colitis recurrence
by: Kaito Tsujinaka, et al.
Published: (2025-04-01)

Case Report: Upadacitinib in the management of refractory urticarial vasculitis
by: Maan M. Almaghrabi, et al.
Published: (2025-08-01)

Associations of Hidradenitis Suppurativa with Atopic Dermatitis: A Review of Shared Pathogenesis and Approach to Treatment of Concomitant Disease
by: Rayad B. Shams, et al.
Published: (2025-06-01)

The diagnosis and management of atopic dermatitis
by: H.F. Jordaan, et al.
Published: (2009-10-01)

Profile of Transepidermal Water Loss in Non-Atopic Dermatitis and Atopic Dermatitis in Indonesian Adults
by: Damayanti, et al.
Published: (2025-03-01)

Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis
by: Diego Dominguez, et al.
Published: (2025-05-01)

Contemporary therapeutic approaches to atopic dermatitis: role of phototherapy and searching for new possibilities
by: I. V. Kosheleva, et al.
Published: (2021-06-01)

Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature
by: Giuseppe Lopalco, et al.
Published: (2025-05-01)

A systematic review of guidelines for the management of atopic dermatitis in children
by: Maya Deva, MBBS, et al.
Published: (2024-12-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Update Management of Atopic Dermatitis
by: Indri Widya Sari, et al.
Published: (2024-11-01)

Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight
by: Francesca Falcinelli, et al.
Published: (2025-04-01)

Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib
by: Mingzhu Yuan, et al.
Published: (2025-12-01)

The impact of abrocitinib treatment on lesion area and pruritus in patients with atopic dermatitis: a systematic review and meta-analysis
by: Xiao-Li Kou, et al.
Published: (2025-07-01)

Childhood Atopic Dermatitis in Taiwan
by: I-Jen Wang, et al.
Published: (2016-04-01)

Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants?
by: Joseph F. Fowler, et al.
Published: (2025-12-01)

Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis
by: Twan Sia, BA, et al.
Published: (2025-05-01)

Treatment of recalcitrant hypertrophic lichen planus with upadacitinib
by: Sabrina F. Schundler, BS, et al.
Published: (2025-05-01)